VolitionRX Limited

VNRX | $0.6172 3.89% 0.0% 260K

(0.0% 1d) (-22.5% 1m) (-63.5% 1y) (0.0% 2d) (5.1% 3d) (-8.7% 7d) (48.07% volume)
Earnings Calendar:
Market Cap: $ 50,652,642
http://www.volition.com
Sec Filling | Patents | 50 employees

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX.

cancer bloodstream

add to watch list Paper trade email alert is off

Press-releases

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -15.38% | O: 1.0% H: 8.11% C: -2.7%
business year update financial results

Volition appoints Dr Andrew Retter as Chief Medical Officer
Published: 2024-03-19 (Crawled : 21:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -27.06% | O: 1.18% H: 1.15% C: -6.98%
medical

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
Published: 2024-02-02 (Crawled : 13:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -42.06% | O: -3.74% H: 5.83% C: 4.37%
update

Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test
Published: 2024-01-12 (Crawled : 13:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -26.19% | O: 1.74% H: 15.59% C: 14.66%
test cancer

Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer
Published: 2023-10-23 (Crawled : 13:00) - biospace.com/
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -20.23% | O: 2.93% H: 10.12% C: 3.95%
test cancer blood

US Ambassador Adler visits Belgian Volition
Published: 2023-10-18 (Crawled : 16:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -25.84% | O: 0.48% H: 5.19% C: 5.19%

Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis
Published: 2023-10-13 (Crawled : 12:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| 0.0% | O: 0.81% H: 11.86% C: 5.6%
report

Volition Hosts Key Opinion Leader Roundtable on Sepsis Management
Published: 2023-09-13 (Crawled : 14:30) - biospace.com/
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -53.73% | O: 1.49% H: 0.0% C: -5.15%
management

VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update
Published: 2023-08-09 (Crawled : 12:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| -48.76% | O: 0.0% H: 6.61% C: 0.83%
conference business update

VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters
Published: 2023-06-23 (Crawled : 21:00) - prnewswire.com
VNRX | $0.6172 3.89% 0.0% 260K

Health Technology

| Email alert Add to watchlist

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001762625-24-000001	4	2024-01-03	2024-01-02	Sell	S	20000	298419
0001477932-23-009191	4	2023-12-18	2023-12-15	Buy	P	10000	89350
0001477932-23-009129	4	2023-12-14	2023-12-13	Buy	P	10000	78652